Key result
Missed acute myocardial infarction (failure to receive reperfusion within 4 hours) was associated with higher 30-day readmission compared to treated STEMI (31.6% vs 3.3%, p=0.001).
Why the study?
Treatment delays or failure to provide reperfusion in STEMI occur more often outside metropolitan areas, but the reasons for this remain unclear.
Does missed diagnosis of acute myocardial infarction (MAMI) worsen clinical outcomes compared to treated STEMI in rural and regional settings?
Cohort (n=100)
Yes
Does missed diagnosis of acute myocardial infarction (MAMI) worsen clinical outcomes compared to treated STEMI in rural and regional settings?
Absolute Event Rate: 31.6% vs 3.3%
p-value: p=0.001
Missed STEMI diagnosis in rural settings, often due to inaccurate ECG interpretation, leads to high inpatient mortality and significantly increased readmission rates and length of stay.
Missed AMI may raise readmission risk; leaves open whether timely reperfusion improves outcomes in broader cohorts.
Background Delay in treatment and/or failure to provide reperfusion in ST-segment elevation myocardial infarction (STEMI) impacts on morbidity and mortality. This occurs more often outside metropolitan areas yet the reasons for this are unclear. This study aimed to describe factors associated with missed diagnosis of acute myocardial infarction (MAMI) in a rural and regional setting. Methods Using a retrospective cohort design, patients who presented with STEMI and failed to receive reperfusion therapy within four hours were identified as MAMI. Univariate analyses were undertaken to identify differences in clinical characteristics between the treated STEMI group and the MAMI group. Mortality, 30-day readmission rates and length of hospital stay are reported. Results Of 100 patients identified as MAMI (70 male, 30 female), 24 died in hospital. Demographics and time from symptom onset were similar in the treated STEMI and MAMI groups. Of the MAMI patients who died, rural hospitals recorded the highest inpatient mortality (69.6% p = 0.008). MAMI patients compared to treated STEMI patients had higher 30 day readmission (31.6% vs 3.3%, p = 0.001) and longer length of stay (5.5 vs 4.3 days p = 0.029). Inaccurate identification of STEMI on electrocardiogram (72%) and diagnostic uncertainty (65%) were associated with MAMI. The Glasgow algorithm to identify STEMI was utilised on 57% of occasions, with 93% accuracy. Conclusion Mortality following MAMI is high particularly in smaller rural hospitals. MAMI results in increased length of stay and readmission rate. Electrocardiogram interpretation and diagnostic accuracy require improvement to determine if this improves patient outcomes.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2019) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=100). Missed acute myocardial infarction (failure to receive reperfusion within 4 hours) vs. Treated STEMI group was evaluated on 30-day readmission (p=0.001). Missed acute myocardial infarction (failure to receive reperfusion within 4 hours) was associated with higher 30-day readmission compared to treated STEMI (31.6% vs 3.3%, p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: